He is the director of Experiential Learning and Clinical Assistant Professor at West Virginia University. He is actively involved in patient care and policy at the WVU Integrative Pain Management Center. And he is the host of the Pain Pod on the Pharmacy Podcast Network.
Today we discuss the implications of President Biden’s decision to issue a mass pardon for those with federal convictions for marijuana possession.
Can lowering tau biology translate into a clinically meaningful slowing of decline in people with early symptomatic Alzheimer’s disease? That is the practical question behind BIIB080, an intrathecal antisense therapy designed to reduce production of tau protein by targeting the tau gene transcript. In a phase 1b program originally designed for safety and dosing, investigators later examined cognitive, functional, and global outcomes as exploratory endpoints. The clinical question matters because current disease-modifying options primarily target amyloid, while tau pathology tracks...
Read more
